VS
BMO SPDR Health Care Select Sector Index ETF (ZXLV) and BMO Global Health Care Fund Active ETF Series (ZGHC) offer distinct profiles for Canadian ETF investors. A direct comparison shows that ZXLV focuses its top 3 sector exposures on Healthcare and Consumer Non-Cyclicals, while ZGHC leans towards Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals. When evaluating costs, ZXLV features a management fee (MER) of 0.21%, compared to 1.02% for ZGHC. Performance-wise, ZXLV has returned 8.67% year-to-date with +$24 M in net flows, whereas ZGHC is at 3.91% with +$13 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
ZXLV
ZGHC
| AuM | $39.83 M | $15.55 M |
| Management Fees | 0.21% | 1.02% |
| Exp. ratio | 0.21% | 0.82% |
| Tracking Difference | - | - |
Historical performance and flows
As of September 11, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | ZXLV | -2.01% | +6.99% | +8.67% | +20.31% | - |
ZGHC | -2.28% | +3.09% | +3.91% | +10.38% | +23.44% | |
| Flows | ZXLV | -$5 M | +$17 M | +$24 M | +$34 M | - |
ZGHC | -$1 M | +$6 M | +$13 M | -$109 M | +$15 M |
ZXLV vs ZGHC exposure
Countries
ZXLV
USA
97.53%
ZGHC
USA
80.14%
Switzerland
9.03%
Other
10.82%
Sectors
ZXLV
Healthcare
97.51%
ZGHC
Healthcare
97.92%
As of September 11, 2026
Top 10 Holdings
ZXLV
Eli Lilly & Co.
15.48%
Johnson & Johnson
10.51%
AbbVie, Inc.
7.55%
UnitedHealth Group, Inc.
6.41%
Merck & Co., Inc.
5.48%
Thermo Fisher Scientific, Inc.
3.64%
Amgen, Inc.
3.54%
Abbott Laboratories
3.14%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.43%
ZGHC
Eli Lilly & Co.
9.90%
UnitedHealth Group, Inc.
7.55%
Johnson & Johnson
7.08%
Merck & Co., Inc.
6.72%
AbbVie, Inc.
5.73%
argenx SE
4.44%
AstraZeneca PLC
4.23%
Abbott Laboratories
3.96%
Novartis AG
3.75%
Thermo Fisher Scientific, Inc.
3.61%
Diversification
ZXLV
Total weight of top 10 holdings out of 59 total
60.94%
ZGHC
Total weight of top 10 holdings out of 119 total
56.97%
Characteristics
Compare
ZXLV
ZGHC
| Provider | BMO | BMO |
| Management | Passively managed | Actively managed |
| Benchmark | S&P Health Care Select Sector Total Return Index - USD | - |
| Replication Method | ||
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 0.46% | 0.00% |
| Meets ESG criteria | No | No |
| Inception Date | February 2, 2025 | June 26, 2023 |
Frequently asked questions about ZXLV and ZGHC
Which ETF has performed better year to date: ZXLV or ZGHC?
As of September 11, 2026, ZXLV has returned 8.67% year to date, while ZGHC has returned 3.91%. ZXLV is ahead on YTD performance.
Which ETF is larger by assets under management: ZXLV or ZGHC?
As of September 11, 2026, ZXLV manages $39.83 M in assets, while ZGHC manages $15.55 M. ZXLV is the larger fund by AUM.
How are ZXLV and ZGHC managed?
ZXLV is passively managed by BMO. It tracks the S&P Health Care Select Sector Total Return Index - USD benchmark. ZGHC is actively managed by BMO. It does not track an index.
What sectors do ZXLV and ZGHC emphasize?
ZXLV is most exposed to Healthcare and Consumer Non-Cyclicals. ZGHC is most exposed to Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals.
Which ETF is attracting more investor flows: ZXLV or ZGHC?
Year to date, ZXLV has seen +$23.63 M in net flows, compared with +$12.55 M for ZGHC. ZXLV has attracted more net investor money so far.
How do the fees of ZXLV and ZGHC compare?
ZXLV has an expense ratio of 0.21%, while ZGHC has an expense ratio of 0.82%.
What are the top holdings of ZXLV and ZGHC?
ZXLV's largest holdings include Eli Lilly & Co., Johnson & Johnson, and AbbVie, Inc.. ZGHC's top holdings include Eli Lilly & Co., UnitedHealth Group, Inc., and Johnson & Johnson.
Which ETF is more diversified: ZXLV or ZGHC?
ZXLV holds 59 securities, while ZGHC holds 117. On holdings count, ZGHC is the more diversified portfolio.
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.